Literature DB >> 21242482

Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure.

Federico Damilano1, Irene Franco, Cinzia Perrino, Katrin Schaefer, Ornella Azzolino, Daniela Carnevale, Giuseppe Cifelli, Pierluigi Carullo, Riccardo Ragona, Alessandra Ghigo, Alessia Perino, Giuseppe Lembo, Emilio Hirsch.   

Abstract

BACKGROUND: Signaling from phosphoinositide 3-kinase γ (PI3Kγ) is crucial for leukocyte recruitment and inflammation but also contributes to cardiac maladaptive remodeling. To better understand the translational potential of these findings, this study investigates the role of PI3Kγ activity in pressure overload-induced heart failure, addressing the distinct contributions of bone marrow-derived and cardiac cells. METHODS AND
RESULTS: After transverse aortic constriction, mice knock-in for a catalytically inactive PI3Kγ (PI3Kγ KD) showed reduced fibrosis and normalized cardiac function up to 16 weeks. Accordingly, treatment with a selective PI3Kγ inhibitor prevented transverse aortic constriction-induced fibrosis. To define the cell types involved in this protection, bone marrow chimeras, lacking kinase activity in the immune system or the heart, were studied after transverse aortic constriction. Bone marrow-derived cells from PI3Kγ KD mice were not recruited to wild-type hearts, thus preventing fibrosis and preserving diastolic function. After prolonged pressure overload, chimeras with PI3Kγ KD bone marrow-derived cells showed slower development of left ventricular dilation and higher fractional shortening than controls. Conversely, in the presence of a wild-type immune system, KD hearts displayed bone marrow-derived cell infiltration and fibrosis at early stages but reduced left ventricular dilation and preserved contractile function at later time points.
CONCLUSIONS: Together, these data demonstrate that, in response to transverse aortic constriction, PI3Kγ contributes to maladaptive remodeling at multiple levels by modulating both cardiac and immune cell functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242482     DOI: 10.1161/CIRCULATIONAHA.110.950543

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

Review 1.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

2.  IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.

Authors:  Mauro Sbroggiò; Daniela Carnevale; Alessandro Bertero; Giuseppe Cifelli; Emanuele De Blasio; Giada Mascio; Emilio Hirsch; Wadie F Bahou; Emilia Turco; Lorenzo Silengo; Mara Brancaccio; Giuseppe Lembo; Guido Tarone
Journal:  Cardiovasc Res       Date:  2011-04-14       Impact factor: 10.787

3.  Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling.

Authors:  Takeshi Suetomi; Andrew Willeford; Cameron S Brand; Yoshitake Cho; Robert S Ross; Shigeki Miyamoto; Joan Heller Brown
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

4.  Stressed hearts inflame the body (in a good way).

Authors:  Toru Hashimoto; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-21       Impact factor: 11.205

Review 5.  Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling.

Authors:  Takeshi Suetomi; Shigeki Miyamoto; Joan Heller Brown
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-23       Impact factor: 4.733

6.  CaMKIIδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis.

Authors:  Andrew Willeford; Takeshi Suetomi; Audrey Nickle; Hal M Hoffman; Shigeki Miyamoto; Joan Heller Brown
Journal:  JCI Insight       Date:  2018-06-21

Review 7.  Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.

Authors:  Ryan A Frieler; Richard M Mortensen
Journal:  Circulation       Date:  2015-03-17       Impact factor: 29.690

Review 8.  The role of B-cells in heart failure.

Authors:  Andrea M Cordero-Reyes; Keith A Youker; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 9.  In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

Authors:  Ajay M Shah; Douglas L Mann
Journal:  Lancet       Date:  2011-08-20       Impact factor: 79.321

Review 10.  NADPH oxidases in heart failure: poachers or gamekeepers?

Authors:  Min Zhang; Alessia Perino; Alessandra Ghigo; Emilio Hirsch; Ajay M Shah
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.